Artificial Intelligence

Rethinking AI Strategy in Commercial Analytics

  Date : April 01, 2026

  Author : Kalyani Nivsarkar

Improzo Insights
Perspectives from practitioners in commercial analytics and AI

Executive Summary

Commercial analytics in pharma is shifting from static dashboards and retrospective analysis to actively shaping decisions in near real time. As generative and answer-driven systems surface recommendations directly inside workflows, analytics models built for dashboards and post-hoc analysis show their limits. Organizations seeing real impact are not experimenting with more AI tools, but redesigning how decisions are supported, governed, and executed. A decision-centric approach grounded in clarity of ownership, traceability, and operational adoption is becoming essential for scaling AI in commercial settings.

Rethinking AI Strategy in Commercial Analytics: A Decision-Centric View

Asking whether a pharma organization has an “AI strategy” is increasingly the wrong question. The more useful question is simpler and more operational: which commercial decisions do we want to improve, and why aren’t they working today?

In commercial analytics, AI discussions often gravitate toward tools, models, or platforms. But value is rarely created by technology alone. It comes from better decisions made faster, with clearer context, and with confidence in how they were formed. That distinction matters more as generative and answer-driven systems begin to influence decisions earlier in the commercial workflow.

From explaining outcomes to shaping decisions

Advanced analytics and machine learning have supported commercial teams for years — from targeting and segmentation to forecasting and incentive design. Historically, these systems were designed to explain outcomes. Teams reviewed dashboards, debated insights, and translated findings into action.

Answer-driven systems compress that flow. Recommendations now surface directly inside workflows such as call planning, account strategy, or territory optimization — sometimes before a dashboard is opened.

In one large biotech commercial team, early pilots surfaced recommendations directly in call planning. The models performed well, but adoption stalled when field leaders couldn’t explain why certain HCPs were prioritized over others during review discussions. The models were accurate, but accuracy alone was not enough to earn trust at the point of execution.

This creates opportunity, but it also exposes gaps. Systems built for exploration struggle when asked to support real-time commercial decisions. When recommendations appear closer to execution, teams expect clarity: how the recommendation was formed, what data was used, and what assumptions were applied. Without that visibility, confidence erodes quickly, regardless of the model’s performance.

“AI creates value in commercial analytics only when it improves how decisions are made — not when it simply generates more insight.”

A decision-centric foundation for commercial AI

A practical AI strategy in commercial analytics starts by anchoring on decisions, not use cases.

  1. Define the decision and its owner. Whether the decision involves call planning, targeting, or forecasting, clarity on ownership and success criteria is essential. AI should support decisions already embedded in the business, not create parallel processes.
  2. Prioritize use cases based on value and feasibility. Focus on decisions with clear commercial impact, sufficient data, and realistic adoption paths. Ambiguous outcomes and long time-to-value timelines often derail otherwise strong initiatives.
  3. Measure success operationally. Accuracy alone is not enough. Commercial leaders care about adoption, confidence, cycle-time reduction, and impact on execution. Metrics should reflect how decisions are made and acted upon.

Operating model, governance, and enablers

As AI moves closer to execution, organizational design matters as much as technology.

Successful commercial analytics efforts typically align three roles:

  • Consumers: Brand, sales, and commercial ops leaders who rely on recommendations
  • Translators: Individuals who connect business context with data and analytics
  • Producers: Teams responsible for building and maintaining AI capabilities

Governance plays a similar role. Effective governance is not about slowing innovation; it establishes accountability, clarity, and trust. In commercial settings, the ability to explain how a recommendation was formed often matters more than algorithmic sophistication. None of this works without the right enablers. Data quality, interoperable technology foundations, domain-savvy talent, and selective partnerships determine whether AI becomes embedded or remains experimental.

From experimentation to impact

AI delivers sustained value in commercial analytics only when it improves how decisions are made and executed. That requires discipline: monitoring outcomes, reinforcing adoption, and continually aligning AI initiatives with evolving commercial priorities.

A decision-centric approach reframes AI from a collection of tools into an operating capability. For commercial analytics leaders, that shift — more than any specific technology choice — is what separates experimentation from real impact.

About the Authors

Kalyani Nivsarkar

Director, Insights and Analytics

Leave a Reply

Your email address will not be published. Required fields are marked *